Viewing Study NCT04663204


Ignite Creation Date: 2025-12-24 @ 7:52 PM
Ignite Modification Date: 2026-06-05 @ 1:25 AM
Study NCT ID: NCT04663204
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-06
First Post: 2020-12-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy
Sponsor: University of Leicester
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Immunoglobulin A Nephropathy View
None Kidney Diseases View
None Glomerulonephritis, IGA View
None Glomerulonephritis View
None Autoimmune Diseases View
None Immune System Diseases View
Keywords: